In November 2024, Ursodeoxycholic Acid(UDCA) developed by Tianlu Biopharmaceutical successfully obtained HALALCertification from Indonesia. This certification confirms that the productfully complies with the stringent requirements of Islamic Sharia law, providingstrong support for the company’s expansion into the Indonesian and global HALALmarkets. The achievement not only reflects Tianlu Bio-pharmaceutical’s highstandards in product quality and regulatory compliance but also demonstratesits profound understanding and rapid responsiveness to diverse global marketdemands.